Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
292.32 USD | -2.50% |
|
-0.17% | +5.86% |
Feb. 12 | US Department of Justice to stop defending independence of FTC, NLRB, letter says | RE |
Feb. 06 | Cigna Group Shares Fall After Downgrade From Bernstein | MT |
Capitalization | 81.31B 77.58B 73.25B 64.44B 115B 7,057B 128B 869B 322B 2,946B 305B 299B 12,315B | P/E ratio 2024 |
22.8x | P/E ratio 2025 * | 12.2x |
---|---|---|---|---|---|
Enterprise value | 107B 102B 95.99B 84.44B 151B 9,248B 168B 1,139B 422B 3,861B 399B 391B 16,138B | EV / Sales 2024 |
0.41x | EV / Sales 2025 * | 0.41x |
Free-Float |
69.07% | Yield 2024 * |
1.91% | Yield 2025 * | 2.06% |
Last Transcript: Cigna
1 day | -2.50% | ||
1 week | +1.96% | ||
Current month | -0.64% | ||
1 month | +4.04% | ||
3 months | -9.08% | ||
6 months | -14.61% | ||
Current year | +5.86% |







Manager | Title | Age | Since |
---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 59 | 2009-11-30 |
Brian Evanko
DFI | Director of Finance/CFO | 49 | 2020-12-31 |
Paul Sanford
COO | Chief Operating Officer | - | 2021-09-22 |
Director | Title | Age | Since |
---|---|---|---|
David Cordani
CHM | Chairman | 59 | 2021-12-31 |
Bill DeLaney
BRD | Director/Board Member | 69 | 2017-12-31 |
Eric Foss
BRD | Director/Board Member | 67 | 2010-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.33% | 7 M€ | -.--% | ||
2.28% | 33 M€ | +3.51% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-2.50% | +1.96% | -14.30% | +27.65% | 81.31B | ||
-1.44% | -0.67% | +0.38% | +9.05% | 482B | ||
-0.60% | -0.55% | -24.07% | -15.12% | 90.28B | ||
+0.38% | -7.47% | -30.82% | -40.80% | 30.62B | ||
+0.09% | -3.53% | -27.79% | -32.49% | 28.2B | ||
+0.59% | -4.12% | -32.22% | -15.55% | 15.11B | ||
-1.37% | -7.19% | +106.02% | +63.05% | 2.62B | ||
-1.76% | +3.24% | +349.28% | +81.30% | 2.23B | ||
+1.87% | +2.01% | -45.17% | -45.18% | 1.9B | ||
+4.25% | -11.14% | -2.85% | - | 399M | ||
Average | -0.05% | -2.73% | +27.85% | +3.55% | 73.45B | |
Weighted average by Cap. | -1.27% | -0.84% | -5.99% | +4.23% |
2024 | 2025 * | |
---|---|---|
Net sales | 244B 233B 220B 193B 346B 21,168B 384B 2,607B 967B 8,837B 914B 896B 36,940B | 252B 240B 227B 200B 358B 21,875B 397B 2,694B 999B 9,133B 945B 926B 38,175B |
Net income | 3.61B 3.45B 3.26B 2.86B 5.13B 314B 5.69B 38.62B 14.33B 131B 13.54B 13.27B 547B | 6.46B 6.16B 5.82B 5.12B 9.16B 560B 10.16B 69.01B 25.6B 234B 24.2B 23.72B 978B |
Net Debt | 25.24B 24.08B 22.74B 20B 35.8B 2,191B 39.74B 270B 100B 915B 94.59B 92.71B 3,823B | 20.95B 19.99B 18.87B 16.6B 29.71B 1,818B 32.97B 224B 83.05B 759B 78.5B 76.94B 3,173B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-14 | 292.32 $ | -2.50% | 1,579,582 |
25-02-13 | 299.82 $ | +2.44% | 1,670,815 |
25-02-12 | 292.69 $ | -0.86% | 1,712,699 |
25-02-11 | 295.24 $ | +0.83% | 1,202,795 |
Delayed Quote Nyse, February 14, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CI Stock